Tight junctions as targets of infectious agents  by Guttman, Julian A. & Finlay, B. Brett
Biochimica et Biophysica Acta 1788 (2009) 832–841
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbamemReview
Tight junctions as targets of infectious agents
Julian A. Guttman a,⁎, B. Brett Finlay b
a Simon Fraser University, Department of Biological Sciences, Shrum Science Centre, Room B8276, Burnaby, BC, Canada V5A 1S6
b The University of British Columbia, Michael Smith Laboratories, 301-2185 East Mall, Vancouver, BC, Canada V6T 1Z4⁎ Corresponding author. Fax: +778 782 3496.
E-mail address: jguttman@sfu.ca (J.A. Guttman).
0005-2736/$ – see front matter © 2008 Elsevier B.V. A
doi:10.1016/j.bbamem.2008.10.028a b s t r a c ta r t i c l e i n f oArticle history: The epithelial barrier is a c
Received 5 March 2008
Received in revised form 1 October 2008
Accepted 29 October 2008
Available online 14 November 2008
Keywords:
Tight junction
Barrier
Pathogen
Microorganism
Diarrhea
Enterocolitisritical border that segregates luminal material from entering tissues. Essential
components of this epithelial fence are physical intercellular structures termed tight junctions. These
junctions use a variety of transmembrane proteins coupled with cytoplasmic adaptors, and the actin
cytoskeleton, to attach adjacent cells together thereby forming intercellular seals. Breaching of this barrier
has profound effects on human health and disease, as barrier deﬁciencies have been linked with the onset of
inﬂammation, diarrhea generation and pathogenic effects. Although tight junctions efﬁciently restrict most
microbes from penetrating into deeper tissues and contain the microbiota, some pathogens have developed
speciﬁc strategies to alter or disrupt these structures as part of their pathogenesis, resulting in either
pathogen penetration, or other consequences such as diarrhea. Understanding the strategies that
microorganisms use to commandeer the functions of tight junctions is an active area of research in
microbial pathogenesis. In this review we highlight and overview the tactics bacteria and viruses use to alter
tight junctions during disease. Additionally, these studies have identiﬁed novel tight junction protein
functions by using pathogens and their virulence factors as tools to study the cell biology of junctional
structures.
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Polarized epithelial cells are positioned at the interface of the
lumen and the deep cell layers of organs. Of all the cells in the body,
intestinal epithelial cells are the prototypic polarized cell type
displaying distinct apices that contain microvilli and bases that
interact with the basal lamina, where they anchor into components of
the extracellular matrix. Laterally, adjacent cells attach together
through intercellular junctions. There are four different types of
junctions commonly found at these sites. At the most apical
intercellular membranes, three individual junctions (a tight junction
followed by an adherens junction then a desmosome) form an apical
junction complex (Fig. 1) [1]. Components of the apical junction
complex interact with cytoskeletal elements to strengthen their
interactions. Tight and adherens junctions form junction belts that
course throughout tissues and are involved in numerous signaling
events (reviewed by: [2–4]). These junctions attach to actin ﬁlaments
through cytoplasmic adaptor proteins. Consequently, there are three
distinct sub-components that form the individual junctions of the
apical junction complex; 1) transmembrane proteins, 2) cytoskeletal
elements and 3) cytoplasmic scaffolding proteins that attach the two
together.
2. Tight junction overview
Tight junctions are themost apically located intercellular junctions
and appear as membrane fusions by electron microscopy. Despite
their appearance, transmembrane proteins span the intercellularFig.1. Prototypic arrangement of junctions in polarized epithelial cells. The apical junction com
desmosome. Gap junctions and additional desmosomes associate beneath the apical junction
with the basal lamina at the base of the cells. Intermediate ﬁlaments dock into desmosom
junctions.space to restrict the paracellular zone and are crucial for their
function. Often extremely small openings exist extracellularly at these
sites that allow the intercellular passage of nanometer-sized mole-
cules [5], however the seal can be much tighter to even restrict water
molecules [6]. Through altering the function of certain tight junction
proteins, dehydration through the epidermal barrier has been
observed [6]. Tight junction alterations have also been proposed to
be involved in diarrhea generation through a “leak-ﬂux” mechanism
in which water enters the lumen of the intestine through the passive
movement of both water and ions following a break in the intestinal
barrier [7]. Although tight junctions have also been proposed to
function in the segregation of apical membrane-bound proteins from
those at the basolateral membranes, recent studies in polarized
epithelial cells completely devoid of tight junctions have clearly
shown that protein segregation is maintained, thus challenging the
membrane protein gating function of tight junctions [8].
Thus far there are four primary groups of transmembrane proteins
that have been described at conventional epithelial tight junctions;
occludin, members of the claudin family, the junction-adhesion-
molecules (JAMs) and the Coxsackievirus and Adenovirus Receptor
(CAR) proteins. Excellent reviews have described the structure and
function of these components and should be referred to for additional
background [9–11]. Brieﬂy, these proteins can be grouped into 2 main
categories based on their structure. Occludin and the claudins span
the membrane four times and interact with adjacent cells through
their extracellular loops whereas the JAMs and CAR contain
extracellular IgG-like domains that are important for their extra-
cellular attachment.plex is formed from the tight junction, adherens junction and themost apically located
complex along the remainder of the lateral cell membranes. Hemidesmosomes interact
es and hemidesmosomes whereas actin ﬁlaments attach to both tight and adherens
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Common to all of these transmembrane proteins are their ability to
interact with members of the membrane-associated guanylate kinase
(MAGUK) family of cytoplasmic adaptors. The most prominently
studied MAGUK proteins at tight junctions are the zonula occludens
proteins (ZO-1, ZO-2 and ZO-3). ZO-1 was the ﬁrst protein discovered
exclusively at mature tight junctions [12]. It can interact directly with
each of the tight junction transmembrane proteins as well as the actin
cytoskeleton.
4. Pathogenic organisms and the epithelial barrier
The interactions between pathogenic microorganisms and their
hosts have provided researchers with a plethora of scientiﬁc puzzles
to explore to try to understand various mechanisms of infectious
diseases. Although human cells have incorporated epithelial barriers
to block organisms that covet access to deeper cell layers within
tissues, certain pathogens have evolved to exploit, and thus control,
tight junctions to alter this barrier. These pathogens use an array of
tactics to commandeer junctional structures for their advantage. Some
pathogens use tight junction proteins as receptors for their attach-
ment and subsequent internalization. Others destroy the junctions
thereby providing a gateway to the underlying tissue. Infectious
enteric agents that alter tight junctions often elicit inﬂammatory
cascades and cause diarrhea. Some of the strategies bacteria and
viruses use to hijack tight junction are outlined below.
5. Bacteria
5.1. Pathogenic Escherichia coli
Enterohemorrhagic E. coli (EHEC) and enteropathogenic E. coli
(EPEC) are members of a family of extracellular pathogens calledFig. 2. Strategies bacterial and viral pathogens use to alter tight junctions. Transmembrane t
cleavage product from the ZOT protein to alter tight junctions. This protein activates PKCα,
periphery. Rotaviruses use the VP8 fragment of VP4 to alter tight junction components. Th
junction integrity. Salmonellamodiﬁes tight junctions through the use of 4 effectors (SipA, So
ZO-1 from the junctions. Both ZO-1 and JAM are found beneath H. pylori when this bacterium
ﬁlaments associated with Listeria and Shigella actin tails as well as actin-rich pedestals formattaching and effacing (A/E) bacteria that induce the production of
diarrhea in their infected hosts. These pathogens use a syringe-like
delivery apparatus, called a type-three secretion system (T3SS), to
inject pathogenic effector proteins from the bacterial cytosol directly
into the cytoplasm of host cells to collapse (efface) localized microvilli
(reviewed by:[13,14]), control the functions of organelles [15],
rearrange the cytoskeleton and membrane channels (reviewed by:
[16]), and disrupt intercellular tight junctions [17–20].
Tight junction alterations have been documented during these
infections for decades as exempliﬁed by decreases in trans-epithelial
resistance (TER) during incubations of cultured cells (MDCK, T84 and
Caco-2) with EPEC. However, as TER indiscriminately calculates the
electrical conductance between apical and basal compartments
through themeasurement of ion conductance and because a difference
in [3H]inulin penetration across infected monolayers did not occur
during the initial study, despite a decrease in TER in polarized Caco-2
andMDCK cells infected for up to 10 hwith EPEC, the authors rightfully
did not conclude a breach in the tight junction barrier due to a lack of
additional evidence [21]. The conclusion that tight junctions were
broken during these infections came from Spitz et al. [22] who used
TER as well as sodium/mannitol ﬂux studies on 6 hour EPEC infected
T84 cells. Subsequent work conﬁrmed this conclusion and has since
demonstrated that occludin [19], ZO-1 [23] and importantly the barrier
forming claudin proteins [18] are dissociated from the cell periphery
during these infections. Electron microscopic analysis has also shown
that tight junction strands are extensively morphologically altered by
EPEC during these infections [18]. Threemultifunctional EPEC effectors
have been implicated in disrupting tight junctions; E. coli secreted
protein F (EspF) [17], E. coli secreted protein G (EspG) [24] and the
mitochondrial associated protein (Map) [25] (Fig. 2). During infections
using EPEC strains mutated in individual effectors, each of these has
demonstrated improvement in tight junction integrity either through
microscopic observation,molecular tracer permeability of infected cell
monolayers or TER.ight junction components associate with actin ﬁlaments through ZO-1. V. cholera uses a
which acts on junction associated actin ﬁlaments. ZO-1 is also dissociated from the cell
e A/E bacteria use the translocated effector proteins EspF, EspG and Map to alter tight
pB SopE and SopE2). H. pylori translocates the effector CagA that alters the localization of
is bound to non-junctional sites. ZO-1 also associates with the distal portions of actin
ed by the A/E pathogen enteropathogenic E. coli (EPEC).
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of molecular motors that use this ﬁlament system as tracts can impact
the downstream effects on junctions. Consequently, studies have
found that during these infections tight junctions can be inﬂuenced
through the actions of myosin II following the activation of myosin II
light chain kinase (MLCK). In this model, MLCK (a protein responsible
for phosphorylating the light chains of myosin) activates the
mechanoenzyme, inducing the contraction of the actin ﬁlaments
docked to the junctions, thus “pulling open” the junction. The work
testing this proposal during EPEC infections comes primarily from
examinations using the pharmacological MLCK inhibitor ML-9 on 6–8
hour infected T84 cells [26]. Studies have correlated a preservation of
tight junction integrity, through TER measurements, during ML-9
treatment thus implicating MLCK in the observed tight junction
alterations. However a signiﬁcant drawback of this drug treatment is
the non-speciﬁc effects inherent in pharmacological studies. To
overcome these challenges and determine the precise role of MLCK
on tight junctions in general, Shen et al. [27] recently performed an
elegant and extensive study using an inducible construct of MLCK in a
polarized Caco-2 epithelial cell line. They determined that although
occludin, ZO-1 and TER were altered, these alterations did not
correspond to an expected alteration in claudins or tight junction
morphology, both of which remained unchanged. Thus, because it is
currently understood that claudins and likely not occludin or ZO-1 are
crucial for maintaining the barrier function of tight junctions, and
evidence shows that tight junctions are morphologically disrupted
and claudins are extensively altered during EPEC infections a re-
evaluation of the speciﬁc role of MLCK during this disease is required.
EPEC and EHEC are primarily human pathogens and consequently
do not colonize mice to appreciable levels or cause any discernable
disease phenotypes [28]. In order to translate the phenotypes seen in
vitro to the whole animal, researchers have used another related A/E
pathogen, Citrobacter rodentium, as an in vivo model of these
infections. C. rodentium are natural murine pathogens that colonize
the colons of infected mice and like the human A/E pathogens,
generate diarrhea as part of their disease manifestations [29]. These
bacteria contain homologous effectors to EPEC and EHEC thus
allowing for the evaluation of effector functions in vivo. Recently, it
was shown that the barrier function of tight junctions, claudin
alterations and morphological disruption seen during in vitro studies
also occur in the course of these in vivo infections [30,31]. C.
rodentium-based tight junction modiﬁcations were dependent on
the bacterial protein EspF but not Map or EspG (unpublished), as
bacteria mutated in espF retained fully functional andmorphologically
intact tight junctions [30].
Evidence suggests that the mechanisms of A/E bacterially-induced
tight junction alterations are likely not through the direct function of
effectors on tight junction proteins themselves. Studies aimed at
localizing EspF in infected cells failed to localize this multifunctional
protein at the cell periphery, but rather localized it at mitochondria
[15]. This is not terribly surprising because if EspF were to bind to the
junction to cause its effects, one could predict that the junction
proteins involved would likely be removed from those sites upon
EspF/tight junction protein interaction. A recent in depth examination
of the role of EspF during Rabbit EPEC (REPEC) infections has further
analyzed the properties of this effector. In that study, the authors
found that REPEC EspF has ∼30% homology with the actin associated
proteinsWASP, N-WASP,WAVE-Scar andWIP [32]. Through additional
investigation they were able to immunoprecipitate both actin and
proﬁlin using anti-EspF antibodies during short-term (1–3 h) infec-
tions on rabbit kidney cells (RK13 cells). Actin was also immunopre-
cipitated by the anti-EspF antibodies using puriﬁed actin and EspF
proteins [32].
During REPEC infections on RK13 cells EspF remained localized
within the cytoplasm where it was likely associating with organelles.
These infections generated an increase in cytoplasmically locatedclaudin and occludin, and together with ZO-1 and ZO-2, these four
proteins were all recruited to actin-rich sites generated beneath these
A/E bacteria called pedestals [32]. This recruitment corroborates
work by Hanajima-Ozawa et al. [33] that showed that ZO-1 localized
to EPEC pedestals which was primarily concentrated at the most
distal portions of these structures (Fig. 2). ZO-1 at EPEC pedestals was
dependent on the proline-rich region of ZO-1 as constructs with that
region deleted from ZO-1 that were transfected into HeLa cells then
infected with EPEC did not get recruited to these structures.
Conversely, when the proline-rich region alone was transfected into
cells then infected, this portion of ZO-1 was again found at the distal
portion of pedestals [33]. This surprising discovery was also evident
in other bacterially-induced actin-rich structures including actin
comet tails generated by Listeria monocytogenes and Shigella ﬂexneri
(Fig. 2).
Despite not knowing the detailed mechanisms of tight junction
alteration during A/E infections, recent work has demonstrated that
probiotic pre-treatment of cultured MDCK and T84 cells with strain
GG of Lactobacillus rhamnosus prior to 3 h EHEC infections prevented
tight junction barrier alterations [34]. Although the presence of L.
rhamnosus did not alter the growth of EHEC, presented evidence
showed few (if any) any attached bacteria. Even though this work
does not advance our knowledge on the mechanism of tight junction
alterations caused by EHEC, it does present an important step in
potentially treating this disease.
5.2. Salmonella
Salmonellae are the causative agents of a variety of diseases
ranging from diarrhea-generating gastroenteritis to systemic typhoid
fever. These pathogens actively invade non-phagocytic cells through
the use of effector proteins encoded on a Salmonella Pathogenicity
Island (SPI1) that they inject into the host cells through a needle-like
apparatus, similar to that of the A/E bacteria. Certain effectors found
within SPI1 act on small GTPases to induce actin dynamics that result
in the generation of host cell membrane rufﬂing in the area of the
extracellular Salmonella bacteria (Fig. 2). This rufﬂing leads to the
engulfment of these bacteria, thus delivering them into the host cell
within a membrane containing vacuole that serves as a protective
niche from lysosomal degradation. Salmonella also induces the
disruption of host cell tight junctions during these infections. This is
exempliﬁed through decreases in TER, increases in tracer permeability
and tight junction protein alterations when assessed in a variety of cell
lines including MDCK, CaCo-2 and T84 cells [35–40]. In vitro
experiments examining speciﬁc tight junction protein alterations
have found that Salmonella causes a decrease in both ZO-1 expression
and in the amount of phosphorylated occludin by 2 h of T84 cell
infections [38]. Occludin is thought to be phosphorylated when at
tight junctions, thus this reduction implies that less occludin is
present at tight junctions during these infections. Although ZO-1 and
occludin are likely not crucial for the barrier function, the claudins are.
However, the surprising ﬁnding of an increase in the presence of
claudin-1 at the cell border was recently documented during Salmo-
nella infections [38]. These experiments did not co-localize the Sal-
monella bacteria in the cells, thus we are unable to be certain that the
cells with the increased intensity of ﬂuorescent claudin-1 staining
were being actively infected.
Studies aimed at elucidating the speciﬁc bacterial proteins
involved in the documented Salmonella-induced tight junction
alterations have primarily used mutated strains of Salmonella to
identify those that do not alter TER, ZO-1 and occludin localization.
Through these experiments, the SPI1 effectors; SopB (SigD), SopE,
SopE2 and SipA have all been implicated in tight junction alterations
[37,39] (Fig. 2). This suggests that synergistic and potentially
redundant mechanisms are in place to ensure tight junctions are
modiﬁed as part of the disease imparted by Salmonella.
Fig. 3. Regions of claudin proteins that are involved in hepatitis C virus and Clostridium
perfringens disease. The hepatitis C virus speciﬁcally interacts with the N-terminal 1/3
of the ﬁrst extracellular loop (EL1) of claudin-1. The second extracellular loop (EL2) of
claudins-3 and -4 are the sites of Clostridium perfringens enterotoxin action.
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tight junction stabilizer. T84 cells that were infected with Salmonella
enterica serovar typhimurium (Salmonella Typhimurium) mutated in
avrA showed decreased expression of ZO-1, claudin-1 and occludin.
When claudin and ZO-1 proteins were immunolocalized on AvrA− S.
Typhimurium infected T84 monolayers, ZO-1 remained localized at
the cell periphery as did Claudin-1, however the authors commented
that ZO-1 appeared thinner and claudinmore disorganized [41]. There
are numerous in vivo animal models of Salmonella-based infections.
Two of the most well-characterized utilize mice. One models the
gastroenteritis disease [42] and the other mimics systemic typhoid
disease (reviewed by: [43]). AvrA was also analyzed using the in vivo
gastroenteritis model [41]. Although similar alterations to those found
during cultured cell infections were reported by the authors, in the
presented images throughout the entire manuscript there was a
severe lack of bacteria interacting with the cells or tissues [41].
Consequently, it will be important to conﬁrm and present evidence
that these ﬁndings occur to cells that are being actively infected by
these pathogens.
5.3. Helicobacter pylori
The bacterial pathogenH. pylori increase the risk of gastroduodenal
ulcers and gastritis. Like Salmonella and pathogenic E. coli, these
organisms also deliver effector proteins into host cells, however these
pathogens use an alternative delivery apparatus called a type-four
secretion system (T4SS), which employs a different set of apparatus
proteins (reviewed by: [44]). During their pathogenesis, H. pylori
preferentially attach at the intercellular boundaries of epithelial cells
and disrupt the function of tight junctions [45]. Consequently, these
infections also result in the mis-localization of the overall homo-
geneous distribution of ZO-1 that is normally found at the cell borders,
resulting in disjointed staining at the cell periphery [45,46]. During
infections ranging from 7 min to 8 h on MDCK and AGS (gastric
adenocarcinoma) cell lines, some bacteria also attach at non-
junctional sites and recruit ZO-1 and JAM beneath the area of bacterial
contact [45] (Fig. 2). Key to the tight junction alterations are two
bacterial effectors, CagA and VacA (vacuolating toxin). Infections with
CagA/VacA double mutants retain an intact epithelial barrier where as
single mutant H. pylori infections cause barrier defects in MDCK cell
monolayers particularly during long-term (1–10 days) in vitro
infections [45].
Although the combination of CagA and VacA synergistically
inﬂuence tight junctions, evidence suggests that both factors can
also alter the function of the junctions independently. In studies
that examined the role of CagA during tight junction formation,
CagA mutant H. pylori infections permitted tight junctions to re-
form following Ca2+ switch experiments, whereas wild-type H.
pylori did not [45]. ZO-1 recruitment to bacteria attached to non-
junctional sites also occurred in a CagA dependant manner [45].
These mutant bacteria also did not concentrate at the cell
boundaries during infections [45]. Transfection experiments that
focused on examining the speciﬁc functions of the CagA protein
alone, demonstrated that GFP-tagged CagA, delivered into epithelial
cells, severely mis-localized ZO-1 to the basal membrane of the cell
[47].
The extent of the inﬂuence of VacA on tight junctions comes
primarily from studies using puriﬁed VacA. VacA induced a decrease
in TER in MDCK cells during short exposures (b1 h) and T84 as well as
epH4 cells during 5–7 h VacA treatments. This protein did not alter
TER in CaCo-2 cells even after 20 h. VacA also caused an increase in
MDCK and T84 monolayer permeability to small molecular weight
molecules and ions when treated for 1.5 h until 24 h time points
[48,49]. Despite these physiological measurements, the localization
and the abundance of ZO-1, occludin and cingulin remained unaltered
even during 24 h treatments [48].The tight junction protein alterations induced by H. pylori appear
to be strain speciﬁc. A study by Fedwick et al. [50] found that using an
alternative strain (strain SS1) a redistribution of occludin, claudin-4
and -5 was detected and a decrease in abundance of these proteins
was also evident during in vitro cultured cell infections with this strain
of H. pylori. This decrease also resulted in tight junction barrier
deﬁcits. Surprisingly, ZO-1 and JAM were unaffected during these
infections and VacA or CagA did not inﬂuence observed alterations.
They also showed that during in vivomurine infections a barrier defect
occurs [50].
5.4. S. ﬂexneri
S. ﬂexneri are pathogens that actively invade non-phagocytic cells
through the use of T3SS-delivered effectors and cause severe
inﬂammatory diarrhea, including dysentery. Although few studies
have examined the effects Shigella have on tight junctions, one
detailed examination by Sakaguchi et al. [51] revealed that it,
extensively disrupts these structures. In polarized cultured T84
epithelial cells, ZO-1, claudin-1 and the phosphorylation status of
occludin were all affected by S. ﬂexneri [51]. Importantly during the
early stages of the infections (10 min) with S. ﬂexneri exposed to the
apical aspects of the cells, claudin-1 protein expression was initially
severely depressed. The claudin-1 protein levels associated with the
membrane returned to approximately 50% of the control levels by
90 min of S. ﬂexneri exposure. Despite a general decrease in TER by the
90 minute time point, TER levels during 10 and 30 minute exposures
of S. ﬂexneri to the apices of these cells resulted in an increase in TER
over baseline standards [51]. Even with the clear evidence that
numerous aspects of tight junction function and molecular architec-
ture are inﬂuenced by these diarrhea-generating pathogens much
more work is needed to explain how the inconsistencies in TER,
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pathogen. Additionally, the role of speciﬁc effectors has not been
clearly assessed. It will be important to elucidate this crucial interplay
to understand the role tight junction modiﬁcations truly play during
these infections.
5.5. Clostridium perfringens
Although numerous bacteria have been implicated in altering tight
junctions, few pathogenic factors have been shown to directly interact
with tight junction proteins. The most in depth analysis of direct tight
junction protein interaction by a bacterial factor comes from analysis
of C. perfringens, a pathogen that causes food poisoning. This
bacterium uses a potent enterotoxin to bind to claudins-3 and -4
[52]. Claudins interact with their family members through two
heterogeneous extracellular loops, EL1 and EL2 (Fig. 3). EL1 from a
claudin protein in one cell associates with EL2 from the adjacent cell.
Detailed analysis has identiﬁed residues 290–319 of this toxin as the
region that binds to the second extracellular loop of claudins-3 and -4
[53,54] (Fig. 3). The claudin binding site of this toxin has beenFig. 4. Reovirus and coxsackievirus association at tight junctions. The reovirus surface protein
used as a receptor for reovirus internalization. The coxsackievirus initially associates with
subsequent movement of the coxsackievirus towards the tight junctions. At tight junctions
internalization. This internalization requires the presence of occludin.crystallized by using residues 194–319 as residues 290–319 resulted in
an unstable fragment [55]. This data will provide important structural
information for speciﬁc therapeutic intervention.
6. Viruses
Tight junction transmembrane proteins are the most exposed
intercellular junctions components that pathogens encounter during
their interactions with host cells. Consequently, some viruses have
exploited these proteins as receptors for their subsequent
internalization.
6.1. Hepatitis C virus (HCV)
HCV is a microbial agent responsible for cirrhosis of the liver. These
pathogens use the claudin transmembrane proteins as receptors for
their internalization. In addition to requiring other membrane factors,
this virus targets the N-terminal third of extracellular loop 1 of
claudin-1 as a co-receptor for entry into eukaryotic cells [56,57]
(Fig. 3). This interaction is highly speciﬁc, as an alteration of 2 aminoσ1 associates with the N-terminal domain of the tight junction protein JAM-A. JAM-A is
the membrane protein DAF. This interaction induces the clustering of DAF and the
the coxsackievirus interacts with CAR and is internalized through caveolin-mediated
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abolishes the internalization of HCV into cells [56]. Very recent work
has also shown that in endothelial cells, claudins-6 and -9 are also
suitable co-factors for HCV entry [58]. However, these claudins do not
efﬁciently allow HCV invasion into hepatoma cells [58].
6.2. Reovirus
Reoviruses are prevalent infectious agents in children causing
respiratory and gastrointestinal diseases. In infected mice, these
pathogens can cause encephalitis. These viruses contains 10 segments
of double-stranded RNA encapsulated in a protein coat and use JAM-A
as a receptor for their attachment and subsequent internalization into
host cells [59–61] (Fig. 4). This virus/host cell interaction occurs
through the direct association of the viral surface protein σ1 to the
amino (N-) terminal domain of JAM-A [59,62] (Fig. 4).Fig. 5. Adenoviruses interact with the D1 domain of CAR through the knob region of the ade
involved in virus release (2).6.3. Rotavirus
Rotaviruses are a major cause of viral gastroenteritis leading to
diarrhea and morbidity in mammals. These organisms consist of a 3
layered protein core, housing double stranded RNA segments. 60
protein spikes surround this core. Each spike is formed by a VP8 and
VP5 subunits, which together are referred to as VP4. Tryptic cleavage
of VP8 from VP5 allows the VP8 fragment to alter the localization of
claudin-3, ZO-1 and occludin, which consequently leads to the
disruption of the barrier integrity of tight junctions during these
infections [63–66]. VP8 can also block the formation of tight junctions
in MDCK cells [63].
Rotaviruses also produce a toxin called NSP4. This viral toxin has
also been shown to block the formation of tight junctions in polarized
MDCK cells [67]. Additionally, this toxin inhibited the localization of
ZO-1 to MDCK cell borders prior to monolayer conﬂuency [67]. Thesenovirus “Fibre” protein. This association is used for both virus internalization (1) and is
839J.A. Guttman, B.B. Finlay / Biochimica et Biophysica Acta 1788 (2009) 832–841disruptions may not only inﬂuence the diarrhea phenotype of this
infection, but also exposes the deeper membrane associated integrin
proteins to rotavirus, which act as receptors for these pathogens
(reviewed by: [68]).
6.4. Adenovirus
Adenoviruses-2 and -5 use the Coxsackievirus and Adenovirus
Receptor protein both as a receptor [69] for their internalization and to
break the epithelial barrier during viral escape [70] (Fig. 5). These
viruses accomplish this through interactions of the most distal
proteins projecting from the virus core, the knob region of the ﬁbre
protein, by directly binding to the N-terminal, D1 extracellular
component of CAR (Fig. 5). The CAR/knob interaction is a higher
afﬁnity interaction than CAR/CAR dimer attachment thus providing a
mechanism of CAR-based tight junction disruption. Concurrent with
the CAR alterations is a decrease in TER, suggesting functional tight
junction breakdown by these viruses.
6.5. Coxsackievirus
Coxsackieviruses are the causative agents of meningitis and
myocarditis. During infections by coxsackievirus-B, these pathogens
use CAR the as a co-receptor for their internalization [69]. In order for
coxsackievirus-B to infect polarized cell layers these viruses initially
attach to the decay-accelerating factor (DAF) surface proteins [71].
These proteins are abundantly dispersed along the apical membranes
of epithelial cells and cluster upon contact with this virus (Fig. 4).
This clustering leads to the activation of the src kinases, Abl and Fyn
[71]. Abl activates the small G-protein Rac within the host cells that
leads to the re-arrangement of the actin cytoskeleton that enables
the viruses to move to the tight junctions. The viruses subsequently
interact with CAR, and are internalized through a caveolin-based
mechanism [72] (Fig. 4). Their internalization also requires occludin
as cells deﬁcient in occludin do not efﬁciently internalize coxsack-
ievirus-B [72] (Fig. 4).
6.6. Discovery of zonulin from Vibrio cholerae's zonula occludens toxin
(ZOT)
V. cholerae, the causative agent of severe watery diarrhea, induces
tight junction alterations through the use of a bacterial surface protein
called the zonula occludens toxin (ZOT). This protein caused a
decrease in epithelial resistance in the ilium of rabbits and the mis-
localization of occludin and ZO-1 in CaCo-2 cells [73–76]. The
mechanism that this pathogenic protein uses to reversibly alter tight
junction integrity is likely through the cleavage of a 12 kDa C-terminal
fragment, which is excreted upon contact with intestinal epithelial
cells [77]. Thus far a direct modiﬁcation to the tight junction proteins
responsible for the barrier function has not been identiﬁed, however
ZOT does alter the actin ﬁlament regulatory protein PKCα, which is
proposed to inﬂuence tight junction permeability [78].
The characterization of ZOT led Wang et al. [79] to postulate that a
mammalian homologue may exist that controls tight junction
paracellular permeability. Through puriﬁcation of cellular proteins
using anti-ZOT antibodies a homologue of ZOT, zonulin, was identiﬁed
in the small intestine, heart and brain, but not the colon [79]. During
pathogenic E. coli and Salmonella infections ex vivo, increases in
zonulin production from the small intestine were evident [80].
7. Conclusion
Cellular microbiologists continue to elucidate the strategies
pathogens use to exploit host cells. We have overviewed how bacteria
and viruses modify tight junctions, however apart from few instances
the detailedmechanisms that thesemicroorganisms employ to inducethese alterations remain elusive. Although advances have led to an
overall greater understanding of these junctional modiﬁcations, there
are still controversies that need to be rectiﬁed. It is fairly evident based
on current data, that there will not be a uniﬁed strategy employed by
all pathogens. Consequently, discovering the binding partners of
effectors that inﬂuence tight junctions are crucial as many virulence
factors likely act upstream of the junctions themselves. The knowl-
edge we will gain through determining these modes of action will not
only be applicable to tight junction alterations caused by pathogens,
but will also be relevant to general tight junction physiology.
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